Company Overview

Aurora Spine Corporation is a medical device company focused on the development, manufacturing, and commercialization of minimally invasive spinal implant systems. The company operates within the orthopedic and spinal medical devices industry, primarily addressing surgical treatment of degenerative spine conditions. Its core products are used in spinal fusion and stabilization procedures, with revenue primarily generated from the sale of proprietary implant systems and related surgical instruments.

The company targets spine surgeons, hospitals, and ambulatory surgical centers, with a strong emphasis on minimally invasive surgery (MIS) techniques designed to reduce operative time and patient recovery periods. Aurora Spine positions itself through surgeon-driven product design, a focused product portfolio, and intellectual property around its implant technologies. The company was founded in 2011 by Trent Northcutt, evolving from an early-stage developer into a commercial-stage spinal implant manufacturer with FDA-cleared products and established U.S. distribution.

Business Operations

Aurora Spine conducts its operations primarily through its wholly owned subsidiary, Aurora Spine USA, Inc., which manages product development, regulatory affairs, sales, and distribution. The company generates revenue through the direct sale of spinal implants and surgical systems, including interbody fusion devices, pedicle screw systems, and minimally invasive access solutions. Key product lines include proprietary MIS-focused spinal fusion platforms designed for lumbar and thoracic procedures.

Operations are concentrated in the United States, where the majority of sales are generated, supported by independent sales representatives and distributor networks. The company controls its product design and intellectual property while leveraging third-party manufacturers for production. Public disclosures do not indicate material joint ventures; however, Aurora Spine maintains commercial relationships with distributors and logistics providers to support market access and inventory management.

Strategic Position & Investments

Aurora Spine’s strategy centers on expanding its minimally invasive spine portfolio, increasing surgeon adoption, and improving operating leverage through scaled U.S. sales. Growth initiatives have focused on launching next-generation implant systems, enhancing procedural efficiency, and broadening indications for existing FDA-cleared products. The company emphasizes organic growth rather than large-scale acquisitions.

Strategic investments have primarily been directed toward research and development, regulatory clearances, and intellectual property protection rather than external equity investments. Aurora Spine has also invested in expanding its sales infrastructure and distributor relationships in high-growth U.S. spine markets. Public filings indicate no material ownership of unrelated portfolio companies; the company remains narrowly focused on spine-focused medical technologies.

Geographic Footprint

Aurora Spine is headquartered in Carlsbad, California, while its parent company is publicly listed in Canada on the TSX Venture Exchange under the symbol ASG.V. The company’s operational footprint is primarily concentrated in North America, with the United States representing the vast majority of revenue and commercial activity.

While Aurora Spine has regulatory clearances that support potential international expansion, disclosed operations and revenue remain predominantly U.S.-based. International sales outside North America have been limited and are not described as a material contributor to overall financial performance in publicly available disclosures.

Leadership & Governance

Aurora Spine is led by a management team with experience in spinal medical devices, product commercialization, and sales execution. The leadership philosophy emphasizes surgeon collaboration, disciplined product development, and capital-efficient growth within the spine market.

Key executives include:

• Trent Northcutt – President & Chief Executive Officer
• Wayne Sawyer – Chief Operating Officer
• John Winslow – Chief Financial Officer

The company operates under a board-governed structure consistent with Canadian public company requirements, with oversight of strategy, financial reporting, and executive compensation aligned with shareholder interests.